<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02968537</url>
  </required_header>
  <id_info>
    <org_study_id>INTRA-2016-00988</org_study_id>
    <nct_id>NCT02968537</nct_id>
  </id_info>
  <brief_title>Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders</brief_title>
  <acronym>INTRA</acronym>
  <official_title>Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinic S端dhang</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Forel Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Psychiatric Center Muensingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bern</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate the effects of a short computerized training as a therapeutic
      add-on to standard therapy in patients with alcohol-use disorder.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Therapeutic interventions to treat alcohol use disorders (AUD) still need to be improved. A
      novel alcohol-specific inhibition-training seems to be a promising new intervention. In this
      study, recently abstinent patients with AUD attending an inpatient treatment program will be
      randomly assigned to one of two alcohol-specific inhibition-training groups (varying in
      Go/NoGo-ratio) or to a control condition. Besides the effects on drinking behavior,
      inhibition and implicit attitudes, the investigators expect the training to influence
      neurophysiological reactivity to alcohol related stimuli. A subgroup of patients will
      therefore additionally undergo EEG recording so that the neurophysiological effects of the
      training can be assessed and related to clinical outcome. Furthermore, since training effects
      rely on learning processes, the influence of endogenous cortisol level (a
      consolidation-enhancer which peaks in the morning) on training outcome will be examined by
      the variation of daytime of the training. All patients' inhibitory control and implicit
      associations towards alcohol will be measured before and after training. The training effects
      will be examined on proximal outcome variables (e.g. implicit associations, inhibitory
      control, abstinence related self-efficacy, craving) and on distal outcome variables at 3-, 6-
      and 12- months follow-up (e.g. percent abstinent days (primary outcome)).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent days of abstinence 3-months follow-up.</measure>
    <time_frame>3-months follow-up</time_frame>
    <description>Percentage of abstinent days in 3-months follow-up. This will be measured with the timeline follow back (TFB), which is a validated procedure to aid recall of past drinking and evaluates information about drinking behavior.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inhibition Go/NoGo</measure>
    <time_frame>Post training, i.e. between 1 and 7 days after completion of the last (i.e. the 6th) training session</time_frame>
    <description>Inhibitory control as assessed with a Go/NoGo task.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurophysiology of inhibitory Control (Go/NoGo)</measure>
    <time_frame>Post training, i.e. between 1 and 7 days after completion of the last (i.e. the 6th) training session</time_frame>
    <description>Neurophysiological correlates of inhibitory control as assessed with EEG-measurement during the Go-NOGo-task. ERPs in response to NoGo-Stimuli will be calculated and the N2/p3-complex will be analyzed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implicit associations (IAT)</measure>
    <time_frame>Post training, i.e. between 1 and 7 days after completion of the last (i.e. the 6th) training session</time_frame>
    <description>Implicit associations as assessed with an alcohol-related implicit association task (IAT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Abstinence related self-efficacy</measure>
    <time_frame>Post-training (i.e. between 1 and 7 days after completion of the training session); discharge, 3-, 6- and 12-months follow-up</time_frame>
    <description>Self efficacy will be assessed with the alcohol abstinence self-efficacy scale (AASE).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Craving</measure>
    <time_frame>Post-training (i.e. between 1 and 7 days after completion of the last training session); discharge, 3-, 6- and 12-months follow-up</time_frame>
    <description>Craving will be measured with the German version of the Obsessive compulsive drinking scale (OCDS-G).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first drink</measure>
    <time_frame>3-, 6- and 12-months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent heavy drinking days</measure>
    <time_frame>3-, 6- and 12-months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inhibition (SST)</measure>
    <time_frame>Post-training; i.e. between 1 and 7 days after completion of the last (i.e. the 6th) training session</time_frame>
    <description>Inhibitory control will be assessed with a Stop-Signal task</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">246</enrollment>
  <condition>Alcohol Dependence</condition>
  <arm_group>
    <arm_group_label>Alc-IT (50/50) (morning)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Alc-IT (50/50) (morning): This alcohol-specific inhibition-training (Alc-IT) training group will operate with a Go/NoGo ratio of 50/50 (Houben et al. 2011; 2012): This original version of the Alc-inhibition-training will include 80 alcoholic NoGo trials as well as 80 non-alcoholic Go trials. In order to arrive at the same training length while keeping the number of Alc-NoGo-pairings constant and the Go/NoGo-ratio at 50/50, it will additionally include 80 neutral Go-trials as well as 80 neutral NoGo-trials. It will thus consist of 320 trials and take about 10.5 minutes to be completed. In the morning group, this training will be administered within the first 2 hours after awakening.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alc-IT (75/25) (morning)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This version of the alcohol-specific inhibition-training (Alc-IT) will operate with a Go/NoGo-ratio of 75/25. It will equally include 80 Alcoholic NoGo-trials and 80 non-alcoholic Go-trials, but now 160 neutral Go-trials will complete the set. This training will also consist of 320 trials and take about 10.5 minutes. In the morning group, this training will be administered within the first 2 hours after awakening.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control-training (morning)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This group will receive an unspecific inhibition training. this training is of the same length and difficulty as the two Alc-inhibition-trainings. In the morning group, this training will be administered within the first 2 hours after awakening.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alc-IT (50/50) (afternoon)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Alc-IT (50/50) (afternoon): As in the arm &quot;Alc-IT (50/50) (morning)&quot;, this alcohol-specific inhibition-training (Alc-IT) group will operate with a Go/NoGo ratio of 50/50 (Houben et al. 2011; 2012): This original version of the Alc-inhibition-training will include 80 alcoholic NoGo trials as well as 80 non-alcoholic Go trials. In order to arrive at the same training length while keeping the number of Alc-NoGo-pairings constant and the Go/NoGo-ratio at 50/50, it will additionally include 80 neutral Go-trials as well as 80 neutral NoGo-trials. It will thus consist of 320 trials and take about 10.5 minutes to be completed. In contrast to the In the morning group, this afternoon group will receive the training in the afternoon.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alc-IT (75/25) (afternoon)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>As in the arm &quot;Alc-IT (75/25) (morning)&quot;, this version of the alcohol-specific inhibition-training (Alc-IT) will operate with a Go/NoGo-ratio of 75/25. It will equally include 80 Alcoholic NoGo-trials and 80 non-alcoholic Go-trials, but now 160 neutral Go-trials will complete the set. This training will also consist of 320 trials and take about 10.5 minutes. In contrast to the In the morning group, this afternoon group will receive the training in the afternoon.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control-training (afternoon)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>As in the arm &quot;Control-training (morning), this group will receive an unspecific inhibition training. This training is of the same length and difficulty as the two Alc-inhibition-trainings. In contrast to the In the morning group, this afternoon group will receive the training in the afternoon.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Alc-IT (50/50) (morning)</intervention_name>
    <description>This alcohol-specific inhibition-training (Alc-IT) training group will operate with a Go/NoGo ratio of 50/50 (Houben et al. 2011; 2012): This original version of the Alc-inhibition-training will include 80 alcoholic NoGo trials as well as 80 non-alcoholic Go trials. In order to arrive at the same training length while keeping the number of Alc-NoGo-pairings constant and the Go/NoGo-ratio at 50/50, it will additionally include 80 neutral Go-trials as well as 80 neutral NoGo-trials. It will thus consist of 320 trials and take about 10.5 minutes to be completed. In the morning group, this training will be administered within the first 2 hours after awakening.</description>
    <arm_group_label>Alc-IT (50/50) (morning)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Alc-IT (75/25) (morning)</intervention_name>
    <description>This version of the alcohol-specific inhibition-training (Alc-IT) will operate with a Go/NoGo-ratio of 75/25. It will equally include 80 Alcoholic NoGo-trials and 80 non-alcoholic Go-trials, but now 160 neutral Go-trials will complete the set. This training will also consist of 320 trials and take about 10.5 minutes. In the morning group, this training will be administered within the first 2 hours after awakening.</description>
    <arm_group_label>Alc-IT (75/25) (morning)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control-training (morning)</intervention_name>
    <description>This group will receive an unspecific inhibition training. this training is of the same length and difficulty as the two Alc-inhibition-trainings. In the morning group, this training will be administered within the first 2 hours after awakening.</description>
    <arm_group_label>Control-training (morning)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Alc-IT (50/50) (afternoon)</intervention_name>
    <description>As in the arm &quot;Alc-IT (50/50) (morning)&quot;, this alcohol-specific inhibition-training (Alc-IT) group will operate with a Go/NoGo ratio of 50/50 (Houben et al. 2011; 2012): This original version of the Alc-inhibition-training will include 80 alcoholic NoGo trials as well as 80 non-alcoholic Go trials. In order to arrive at the same training length while keeping the number of Alc-NoGo-pairings constant and the Go/NoGo-ratio at 50/50, it will additionally include 80 neutral Go-trials as well as 80 neutral NoGo-trials. It will thus consist of 320 trials and take about 10.5 minutes to be completed. In contrast to the In the morning group, this afternoon group will receive the training in the afternoon.</description>
    <arm_group_label>Alc-IT (50/50) (afternoon)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Alc-IT (75/25) (afternoon)</intervention_name>
    <description>As in the arm &quot;Alc-IT (75/25) (morning)&quot;, this version of the alcohol-specific inhibition-training (Alc-IT) will operate with a Go/NoGo-ratio of 75/25. It will equally include 80 Alcoholic NoGo-trials and 80 non-alcoholic Go-trials, but now 160 neutral Go-trials will complete the set. This training will also consist of 320 trials and take about 10.5 minutes. In contrast to the In the morning group, this afternoon group will receive the training in the afternoon.</description>
    <arm_group_label>Alc-IT (75/25) (afternoon)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control-training (afternoon)</intervention_name>
    <description>As in the arm &quot;Control-training (morning), this group will receive an unspecific inhibition training. This training is of the same length and difficulty as the two Alc-inhibition-trainings. In contrast to the In the morning group, this afternoon group will receive the training in the afternoon.</description>
    <arm_group_label>Control-training (afternoon)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Abstinent patients with an alcohol use disorder in the 12-week inpatient program of
             the Clinic S端dhang or the Forel Clinic,

          -  Abstained from alcohol for at least 4 weeks (in relation to timepoint when training
             will start),

          -  Informed Consent as documented by signature.

        Exclusion Criteria:

          -  Other main psychiatric diagnosis than alcohol use disorder (comorbidity is allowed if
             the alcohol use disorder is to be considered the main diagnosis),

          -  other severe substance use disorder (except nicotine), even as secondary diagnosis

          -  Neurocognitive problems (e.g. Korsakoff syndrome),

          -  Current medical conditions excluding participation (e.g. acute infectious disease),

          -  Inability to read and understand the participant's information,

          -  Enrolment of the investigator, his/her family members, employees and other dependent
             persons.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Stein, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern, University Hospital for Psychiatry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Leila Soravia, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern, University Hospital for Psychiatry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franz Moggi, PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern, University Hospital for Psychiatry</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Stein, PhD</last_name>
    <phone>0041 31 930 9752</phone>
    <email>stein@puk.unibe.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Forel Klinik</name>
      <address>
        <city>Ellikon</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Klinik S端dhang</name>
      <address>
        <city>Kirchlindach</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leila Soravia</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Psychiatric Center Muensingen</name>
      <address>
        <city>M端nsingen</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hallie Batschelet</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2016</study_first_submitted>
  <study_first_submitted_qc>November 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2016</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alcohol use disorders</keyword>
  <keyword>inhibition</keyword>
  <keyword>EEG</keyword>
  <keyword>cortisol</keyword>
  <keyword>Training</keyword>
  <keyword>clinical outcome measures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

